The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)

Paul Holvoet; Nancy S. Jenny; Pamela J. Schreiner; Russell P. Tracy; David R. Jacobs

doi:10.1016/j.atherosclerosis.2006.08.002

The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)

Paul Holvoet, Nancy S. Jenny, Pamela J. Schreiner, Russell P. Tracy, David R. Jacobs

Epidemiology & Community Health

Research output: Contribution to journal › Article › peer-review

113 Scopus citations

Abstract

Several groups have demonstrated an association between established CHD and elevated oxidized LDL (oxLDL). The relation with cardiovascular risk factors and subclinical CVD is less clear. Therefore, we examined this association in the Multi-Ethnic Study of Atherosclerosis cohort: 879 persons without CHD, all non-statin users, examined cross-sectionally. oxLDL was measured with a monoclonal antibody 4E6-based ELISA. The presence of subclinical CVD was defined as plaque occurrence in carotid arteries with ≥25 stenosis, ankle-brachial blood pressure index (ABI) <0.9 and coronary calcification based on Agatston calcium score ≥ 200. In a multivariate model, dyslipidemia (adverse levels of cholesterol, HDL-cholesterol, triglycerides), inflammation (elevated fibrinogen), gender (male), ethnicity (Black), and current smoking explained the most variation in oxLDL (model R² = 0.41). In bivariate analyses, persons with subclinical CVD had higher levels of oxLDL (1.22 mg/dl versus 0.95 mg/dl; P = 0.0002). Adjustment for risk factor correlates attenuated associations with subclinical CVD (P = 0.026). In conclusion, oxLDL is associated with subclinical CVD by its relationship with many cardiovascular risk factors.

Original language	English (US)
Pages (from-to)	245-252
Number of pages	8
Journal	Atherosclerosis
Volume	194
Issue number	1
DOIs	https://doi.org/10.1016/j.atherosclerosis.2006.08.002
State	Published - Sep 2007

Bibliographical note

Funding Information:
This research was supported by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute: Coordinating Center (N01-HC-95159), UCLA Field Center (N01-HC-95160), Columbia University Field Center (N01-HC-95161), Columbia GCRC (RR-0645), Johns Hopkins University Field Center (N01-HC-95162), University of Minnesota Field Center (N01-HC-95163), Northwestern University Field Center (N01-HC-95164), Wake Forest University Field Center (N01-HC-95165), Central Laboratory (N01-HC-95166), Ultrasound Reading Center (N01-HC-95167), MRI Reading Center (N01-HC-95168), CT Reading Center (N01-HC-95169). The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org . In Leuven, the Interuniversity Attraction Poles Program, Belgian Science Policy (P5/02) supported this work. We thank Mrs. M. Landeloos for excellent technical assistance.

Keywords

Atherosclerosis
Cardiovascular disease
Cardiovascular risk
Lipoproteins
Oxidized LDL

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.atherosclerosis.2006.08.002

Find It

Find It at U of M Libraries

Cite this

@article{d11c4faae2f2478bb2efe197c8755d68,

title = "The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)",

abstract = "Several groups have demonstrated an association between established CHD and elevated oxidized LDL (oxLDL). The relation with cardiovascular risk factors and subclinical CVD is less clear. Therefore, we examined this association in the Multi-Ethnic Study of Atherosclerosis cohort: 879 persons without CHD, all non-statin users, examined cross-sectionally. oxLDL was measured with a monoclonal antibody 4E6-based ELISA. The presence of subclinical CVD was defined as plaque occurrence in carotid arteries with ≥25 stenosis, ankle-brachial blood pressure index (ABI) <0.9 and coronary calcification based on Agatston calcium score ≥ 200. In a multivariate model, dyslipidemia (adverse levels of cholesterol, HDL-cholesterol, triglycerides), inflammation (elevated fibrinogen), gender (male), ethnicity (Black), and current smoking explained the most variation in oxLDL (model R2 = 0.41). In bivariate analyses, persons with subclinical CVD had higher levels of oxLDL (1.22 mg/dl versus 0.95 mg/dl; P = 0.0002). Adjustment for risk factor correlates attenuated associations with subclinical CVD (P = 0.026). In conclusion, oxLDL is associated with subclinical CVD by its relationship with many cardiovascular risk factors.",

keywords = "Atherosclerosis, Cardiovascular disease, Cardiovascular risk, Lipoproteins, Oxidized LDL",

author = "Paul Holvoet and Jenny, {Nancy S.} and Schreiner, {Pamela J.} and Tracy, {Russell P.} and Jacobs, {David R.}",

note = "Funding Information: This research was supported by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute: Coordinating Center (N01-HC-95159), UCLA Field Center (N01-HC-95160), Columbia University Field Center (N01-HC-95161), Columbia GCRC (RR-0645), Johns Hopkins University Field Center (N01-HC-95162), University of Minnesota Field Center (N01-HC-95163), Northwestern University Field Center (N01-HC-95164), Wake Forest University Field Center (N01-HC-95165), Central Laboratory (N01-HC-95166), Ultrasound Reading Center (N01-HC-95167), MRI Reading Center (N01-HC-95168), CT Reading Center (N01-HC-95169). The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org . In Leuven, the Interuniversity Attraction Poles Program, Belgian Science Policy (P5/02) supported this work. We thank Mrs. M. Landeloos for excellent technical assistance.",

year = "2007",

month = sep,

doi = "10.1016/j.atherosclerosis.2006.08.002",

language = "English (US)",

volume = "194",

pages = "245--252",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups

T2 - The Multi-Ethnic Study of Atherosclerosis (MESA)

AU - Holvoet, Paul

AU - Jenny, Nancy S.

AU - Schreiner, Pamela J.

AU - Tracy, Russell P.

AU - Jacobs, David R.

N1 - Funding Information: This research was supported by contracts N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute: Coordinating Center (N01-HC-95159), UCLA Field Center (N01-HC-95160), Columbia University Field Center (N01-HC-95161), Columbia GCRC (RR-0645), Johns Hopkins University Field Center (N01-HC-95162), University of Minnesota Field Center (N01-HC-95163), Northwestern University Field Center (N01-HC-95164), Wake Forest University Field Center (N01-HC-95165), Central Laboratory (N01-HC-95166), Ultrasound Reading Center (N01-HC-95167), MRI Reading Center (N01-HC-95168), CT Reading Center (N01-HC-95169). The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org . In Leuven, the Interuniversity Attraction Poles Program, Belgian Science Policy (P5/02) supported this work. We thank Mrs. M. Landeloos for excellent technical assistance.

PY - 2007/9

Y1 - 2007/9

N2 - Several groups have demonstrated an association between established CHD and elevated oxidized LDL (oxLDL). The relation with cardiovascular risk factors and subclinical CVD is less clear. Therefore, we examined this association in the Multi-Ethnic Study of Atherosclerosis cohort: 879 persons without CHD, all non-statin users, examined cross-sectionally. oxLDL was measured with a monoclonal antibody 4E6-based ELISA. The presence of subclinical CVD was defined as plaque occurrence in carotid arteries with ≥25 stenosis, ankle-brachial blood pressure index (ABI) <0.9 and coronary calcification based on Agatston calcium score ≥ 200. In a multivariate model, dyslipidemia (adverse levels of cholesterol, HDL-cholesterol, triglycerides), inflammation (elevated fibrinogen), gender (male), ethnicity (Black), and current smoking explained the most variation in oxLDL (model R2 = 0.41). In bivariate analyses, persons with subclinical CVD had higher levels of oxLDL (1.22 mg/dl versus 0.95 mg/dl; P = 0.0002). Adjustment for risk factor correlates attenuated associations with subclinical CVD (P = 0.026). In conclusion, oxLDL is associated with subclinical CVD by its relationship with many cardiovascular risk factors.

AB - Several groups have demonstrated an association between established CHD and elevated oxidized LDL (oxLDL). The relation with cardiovascular risk factors and subclinical CVD is less clear. Therefore, we examined this association in the Multi-Ethnic Study of Atherosclerosis cohort: 879 persons without CHD, all non-statin users, examined cross-sectionally. oxLDL was measured with a monoclonal antibody 4E6-based ELISA. The presence of subclinical CVD was defined as plaque occurrence in carotid arteries with ≥25 stenosis, ankle-brachial blood pressure index (ABI) <0.9 and coronary calcification based on Agatston calcium score ≥ 200. In a multivariate model, dyslipidemia (adverse levels of cholesterol, HDL-cholesterol, triglycerides), inflammation (elevated fibrinogen), gender (male), ethnicity (Black), and current smoking explained the most variation in oxLDL (model R2 = 0.41). In bivariate analyses, persons with subclinical CVD had higher levels of oxLDL (1.22 mg/dl versus 0.95 mg/dl; P = 0.0002). Adjustment for risk factor correlates attenuated associations with subclinical CVD (P = 0.026). In conclusion, oxLDL is associated with subclinical CVD by its relationship with many cardiovascular risk factors.

KW - Atherosclerosis

KW - Cardiovascular disease

KW - Cardiovascular risk

KW - Lipoproteins

KW - Oxidized LDL

UR - http://www.scopus.com/inward/record.url?scp=34648839885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648839885&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2006.08.002

DO - 10.1016/j.atherosclerosis.2006.08.002

M3 - Article

C2 - 16982059

AN - SCOPUS:34648839885

SN - 0021-9150

VL - 194

SP - 245

EP - 252

JO - Atherosclerosis

JF - Atherosclerosis

IS - 1

ER -

The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this